See more : Elite Pharmaceuticals, Inc. (ELTP) Income Statement Analysis – Financial Results
Complete financial analysis of Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jiangsu Sidike New Materials Science & Technology Co., Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Youngy Health Co., Ltd. (300247.SZ) Income Statement Analysis – Financial Results
- Sonetel AB (publ) (SONE.ST) Income Statement Analysis – Financial Results
- Overseas Shipholding Group, Inc. (OSG) Income Statement Analysis – Financial Results
- China South Publishing & Media Group Co., Ltd (601098.SS) Income Statement Analysis – Financial Results
- Mashreqbank PSC (MASQ.AE) Income Statement Analysis – Financial Results
Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ)
About Jiangsu Sidike New Materials Science & Technology Co., Ltd.
Jiangsu Sidike New Materials Science & Technology Co., Ltd. manufactures and sells multifunctional coating composite material in China. It offers protective material, including computer and phone protective films; electronic grade adhesive materials, such as sided fixing and sided sealing material; functional coating material such as functional protective, conducting functional, insulation functional, shielding, and marked functional material; and film packaging material. The company was founded in 2006 and is based in Suqian, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.97B | 1.88B | 1.98B | 1.54B | 1.43B | 1.35B | 1.29B | 978.64M | 848.81M | 935.49M | 816.91M | 584.75M | 404.45M |
| Cost of Revenue | 1.46B | 1.32B | 1.45B | 1.15B | 1.06B | 1.04B | 986.74M | 726.40M | 650.87M | 746.11M | 626.78M | 439.27M | 304.69M |
| Gross Profit | 512.88M | 557.25M | 534.92M | 386.89M | 371.37M | 307.69M | 302.40M | 252.24M | 197.94M | 189.39M | 190.14M | 145.48M | 99.76M |
| Gross Profit Ratio | 26.05% | 29.69% | 26.96% | 25.13% | 25.92% | 22.87% | 23.46% | 25.77% | 23.32% | 20.24% | 23.28% | 24.88% | 24.67% |
| Research & Development | 197.29M | 127.02M | 109.00M | 94.80M | 82.81M | 67.75M | 73.57M | 49.71M | 0.00 | 40.43M | 38.64M | 0.00 | 0.00 |
| General & Administrative | 35.20M | 45.48M | 38.48M | 30.13M | 23.65M | 17.97M | 19.44M | 19.06M | 97.08M | 81.71M | 70.57M | 51.35M | 33.57M |
| Selling & Marketing | 71.94M | 55.07M | 49.20M | 31.91M | 48.76M | 51.19M | 46.59M | 36.31M | 30.00M | 26.49M | 25.30M | 20.00M | 10.69M |
| SG&A | 107.14M | 100.55M | 87.68M | 62.04M | 72.40M | 69.16M | 66.02M | 55.37M | 127.08M | 108.21M | 95.88M | 71.34M | 44.26M |
| Other Expenses | 163.49M | -2.38M | -1.46M | -31.49M | 12.08M | 1.11M | -5.22M | 12.09M | 10.28M | 11.85M | 7.31M | 19.12M | 9.25M |
| Operating Expenses | 467.91M | 300.27M | 245.31M | 104.10M | 202.46M | 177.45M | 173.81M | 143.79M | 130.60M | 110.42M | 99.58M | 72.25M | 45.79M |
| Cost & Expenses | 1.92B | 1.62B | 1.69B | 1.26B | 1.26B | 1.22B | 1.16B | 870.19M | 781.47M | 856.52M | 726.35M | 511.52M | 350.47M |
| Interest Income | 4.81M | 6.89M | 5.65M | 6.75M | 1.60M | 2.24M | 1.78M | 2.43M | -0.63 | 0.00 | 0.00 | -0.89 | -0.94 |
| Interest Expense | 81.20M | 57.15M | 39.15M | 37.18M | 41.47M | 42.09M | 41.60M | 36.77M | 37.58M | 49.40M | 38.24M | 26.46M | 11.47M |
| Depreciation & Amortization | 249.05M | 182.71M | 122.91M | 94.18M | 92.71M | 89.95M | 83.13M | 73.99M | 46.36M | 58.79M | 49.02M | 32.37M | 20.25M |
| EBITDA | 364.99M | 426.22M | 403.46M | 342.68M | 258.26M | 210.19M | 196.33M | 171.79M | 67.34M | 78.97M | 90.56M | 73.23M | 58.56M |
| EBITDA Ratio | 18.54% | 23.56% | 20.91% | 22.31% | 19.14% | 16.59% | 15.94% | 19.80% | 8.47% | 8.95% | 11.53% | 13.04% | 14.48% |
| Operating Income | 44.97M | 183.41M | 241.44M | 238.31M | 109.82M | 74.91M | 74.38M | 53.03M | 25.56M | 24.95M | 45.16M | 43.86M | 38.30M |
| Operating Income Ratio | 2.28% | 9.77% | 12.17% | 15.48% | 7.67% | 5.57% | 5.77% | 5.42% | 3.01% | 2.67% | 5.53% | 7.50% | 9.47% |
| Total Other Income/Expenses | -7.88M | -1.97M | -1.46M | -31.49M | 12.08M | 1.11M | -5.22M | 12.09M | 10.28M | 9.28M | 7.31M | 19.02M | 8.88M |
| Income Before Tax | 37.08M | 181.43M | 239.98M | 206.83M | 121.90M | 76.02M | 69.15M | 65.11M | 35.84M | 34.23M | 52.48M | 62.88M | 47.18M |
| Income Before Tax Ratio | 1.88% | 9.67% | 12.09% | 13.43% | 8.51% | 5.65% | 5.36% | 6.65% | 4.22% | 3.66% | 6.42% | 10.75% | 11.67% |
| Income Tax Expense | -18.97M | 14.45M | 31.58M | 26.15M | 10.81M | 84.72K | 6.97M | 9.29M | 4.98M | 3.59M | 5.57M | 10.51M | 6.99M |
| Net Income | 56.07M | 168.09M | 209.94M | 181.63M | 111.19M | 76.55M | 63.16M | 55.82M | 30.86M | 30.64M | 46.91M | 52.38M | 40.28M |
| Net Income Ratio | 2.85% | 8.95% | 10.58% | 11.80% | 7.76% | 5.69% | 4.90% | 5.70% | 3.64% | 3.27% | 5.74% | 8.96% | 9.96% |
| EPS | 0.12 | 0.39 | 0.50 | 0.43 | 0.27 | 0.24 | 0.20 | 0.18 | 0.11 | 0.11 | 0.17 | 0.19 | 0.15 |
| EPS Diluted | 0.12 | 0.39 | 0.50 | 0.43 | 0.27 | 0.24 | 0.20 | 0.18 | 0.11 | 0.11 | 0.17 | 0.19 | 0.15 |
| Weighted Avg Shares Out | 467.23M | 427.68M | 423.67M | 419.42M | 418.75M | 315.35M | 314.37M | 312.59M | 283.57M | 274.49M | 275.61M | 276.05M | 267.37M |
| Weighted Avg Shares Out (Dil) | 467.23M | 427.68M | 423.67M | 419.42M | 418.75M | 315.35M | 314.37M | 312.59M | 283.57M | 274.49M | 275.61M | 276.05M | 267.37M |
Source: https://incomestatements.info
Category: Stock Reports